Spanish Society of Medical Oncology Grant (FSEoM)

Scientific research

CRIS Cancer Foundation for Training in Leading Overseas Centres

The Spanish Society of Medical Oncology is a leading oncology organisation with 3,000 oncologist associates practicing in Spain.

Each year, it organises a call for grants. One of these is financed by the CRIS Contra el Cancer Foundation, at a cost of 35,000 euros per year.

The aim is for the grant recipient to participate directly in a translational research project which is already running and/or which can be completed within the allocated time. This grant is specifically designated for projects of a particularly clinical-translational nature. It is a centre of excellence in overseas cancer research.


2 grants for 6 months Training in Leading Overseas Centres.

1. Awardee: Dr. Enrique González Billalabieita

Hospital General Universitario Morales Meseguer de Murcia

Economic Grant 2016: 35.000

Centre: Institute for Cancer Research/Royal Marsden (UK)

2. Awardee: Dr. Ángel Guerrero Zotano

 Economic Grant 2015: 35.000

CentreDel Vanderbilt INgram Cancer Center (Nashville, EEUU)




2 grants for 6 months Training in Leading Overseas Centres. 



Servicio de Oncología Médica del Hospital Universitario y politécnico La Fe de Valencia.

Economic Grant 2015: 35.000

Centre: Royal Marsden NHS Foundation Trust, Londres (UK)

Research Director: Dr. Sanjay Popat

Objetive: Personalised medicine in lung cancer

Timeline: 6 months (starting from sep 2016)



 Servicio de Oncología Médica del Hospital Universitario Rey Juan Carlos de Madrid.

Economic Grant 2015: 35.000

CentreUniversity Hospital, Southampton (UK).

Scientific Research DirectorProf. Diana Eccles

Objetive: Genetic

Timeline: 6 months (Starting from September 2016)



Awardee: Dr. Guillermo de Velasco Oria de Rueda

Centres: Dana-Farber Cancer Institute, Boston (USA)

Timeline: One year

Donations received35,000 €

Dr. Guillermo de Velasco Oria de Rueda, from the University Hospital 12 de Octubre, who will use this grant to perfect his investigation into renal cancer. He will carry out the following projects:

  1. Investigation into prognostic genetic signatures in advanced renal cancer.
  1. Participation in the database of the International mRCC (metastatic Renal cell carcinoma) Database Consortium (IMDC), which includes over 4,000 patients and is constantly updating all clinical information, and at the same time collecting tissue to carry out studies into bio-markers.
  1. Specific study into less-frequent histologies for renal cancer (non-clear cell RCC) from different sources.




Servicio de Oncología Médica del Hospital Clínico Universitario de Valencia.

Centre: The Royal Marsden Hospital. London (UK)

Scientific Research Director: Profesor Johann de Bono

Dr Roda-Pérez studied and trained in Valencia, spending her training period in the Clinical Hospital of Valencia.

“Cancer is a global and complex disease, where clinical training is not enough; medical oncologists must possess both translational training and extensive experience in the laboratory.”

“The centre where I am going to carry out my work is The Royal Marsden Hospital, International Centre of research excellence.”

“I participated in the “Molecular Characterisation Protocol” project, whose objective is next-generation sequencing of all types of cancers.”